The Sanfilippo syndrome type B is a lysosomal storage disorder caused by deficiency of a-N-acetylglucosaminidase; it is characterized by profound mental deterioration in childhood and death in the second decade. For
. Each is due to deficiency of one of four lysosomal enzymes that participate in the removal of sulfated N-acetylglucosamine residues during the degradation of heparan sulfate: heparan N-sulfatase (A subtype), a-N-acetylglucosaminidase (B subtype), acetylCoA:a-glucosaminide acetyltransferase (C subtype), and N-acetylglucosamine 6 -sulfatase (D subtype). In the absence of any one of these enzymes, undegraded or partially degraded heparan sulfate accumulates in lysosomes and is excreted in urine. Profound mental retardation with relatively mild somatic manifestations is characteristic of the Sanfilippo syndrome. The disease is particularly difficult for families because during childhood, developmental delay is often accompanied by intractable hyperactivity; this phase is followed by a more quiet period with progressive loss of mental function. Magnetic resonance imaging shows atrophy of the brain (2) . There is clinical variability between and within the subtypes, and even intrafamilial variability in the B subtype (3, 4) . Patients (8, 9) .
MATERIALS AND METHODS
Purification of a-N-acetylglucosaminidase. Enzyme activity was assayed as described (10) , using the fluorogenic substrate, 4-methylumbelliferyl-a-N-acetylglucosaminide (Calbiochem). Protein concentration was determined by the bicinchoninic acid assay (11) .
An animal source was used as starting material for enzyme purification to avoid exposure to viral pathogens in human tissues. A preliminary survey showed bovine testes (Pel-Freez Biologicals) to be satisfactory with respect to enzyme activity and cost. The enzyme was purified from 3-kg batches by sequential chromatography on concanavalin A-Sepharose, DEAE-Sepharose, and phenyl-Sepharose CL-4B (12) . After this partial purification ('2000-fold), the enzyme was subjected to preparative SDS/PAGE without preheating, a procedure that preserved a-N-acetylglucosaminidase activity. Af (Fig. 1A) . The larger one corresponded precisely to a well-defined protein band and was therefore selected for sequence analysis of amino-terminal and internal peptides. Tryptic digestion was carried out in situ (13 Fig. 1B . Their sequences were as follows: I, 5'-GATCGAATTCATGGT(GATC)GG(GAT-C)AC(GATC)GG(GATC)AT-3'; II, 5'-CATGCTGCAGCA-(GATC)GCCAT(GATC)A(GA)(GATC)GC(GA)TA-3'; and III, 5 '-AT(CTA)GG(GATC)CA(GA)AA(CT)GA(GA)GT-3'. Total RNA (14) The RACE segment, which extended the sequence by 0.6 kb, was used as a probe to rescreen the library. An 0.8-kb segment was isolated but still did not contain sequence corresponding to the amino terminus of the bovine or human enzyme; furthermore, its 5'-end was subsequently found to contain intronic sequence. The sequence corresponding to the amino terminus was finally located in a genomic clone, and RT-PCR of fibroblast RNA was performed in order to identify the exonic sequence. Fig. 1D shows the alignment of the clones.
Isolation of the NAGLU gene. DNA isolated from the normal human fibroblast line IMR 90 (Coriell Institute for Medical Research, Camden, NJ) was digested with EcoRI. A sample was used for Southern hybridization with the upstream 480 bp of the cDNA clone from screen 2 and the 1.5-kb cDNA from screen 1 (Fig. 1D) The PCR primers that produced segments with abnormal migration on SSCP, and the corresponding annealing temperature, were as follows: sense primer, 5'-GCTGGCTAGTGA-CAGCCGCTT-3', and antisense primer, 5'-CTGGTGCTGT-TGGAAAGGGAT-3', 54°C, for GM 00156 (R626X), GM 02552 (R643H), and A and H (R674H); sense primer, 5'-AA-ACCAGGAGCTGTAGAGAAGT-3', and antisense primer, 5'-CTGCCTACCCCTACTGACATCT-3', 54°C, for GM 02552 (R297X); sense primer, 5'-CCCTGCCCATCTGTTA-GACT-3', and antisense primer, 5'-GCACGTTGAAAGCA-CTTCTA-3', 53°C, for IT 154 (503dell0).
The procedures followed for cell lines A and H, the first to be analyzed, differed in that the sequence analysis that revealed the R674H mutation was first performed on RT-PCR amplified samples of total fibroblast RNA. The PCR-amplified segment of genomic DNA was not sequenced; instead, it was incubated with the restriction nuclease BsrI in order to cleave the sensitive site created by the mutation. For allele-specific hybridization, PCR-amplified products from 100 genomic DNA samples (Hadassah Medical Center) were dot-blotted onto a nylon membrane and hybridized with y-32p end-labeled primers corresponding to the normal sequence, 5'-ACACC-CCTCGCTGGCGGCT-3' or the mutant sequence 5'-ACA-CCCCTCACTGGCGGCT-3'. Boldface type indicates mutant sequence.
RESULTS AND DISCUSSION
Characterization of cDNA. Fig. 2 shows the nucleotide sequence of cDNA, determined from the overlapping cDNA and genomic clones, as well as the deduced amino acid sequence. The coding region consists of 743 aa. The translation start site was established by the absence of inframe methionine codons further upstream. Nucleotides -3 to +4 (accATGG) fit the Kozak model of a "strong" initiator site (19) . A hydrophobic stretch of 23 aa, consistent with a signal peptide, extends to the amino terminus of the purified enzyme. Cleavage by signal peptidase at amino acids 20-23 conforms to von Heijne's predictions (20) . Thus in contrast to many other lysosomal enzymes (21), a-N-acetylglucosaminidase of bovine testis and human liver is not processed by further proteolytic cleavage.
The deduced amino acid sequence has six potential Nglycosylation sites of the commonly used NXS/T structure at asparagine residues 261, 272, 435, 503, 526, and 532; an additional site, N513, might not be used because of an adjacent proline (22) . The sequence also includes the rarely used NXC glycosylation signal (22) at N134. The amino acid sequences of eleven of 12 peptides from the bovine enzyme were over 50% identical to the corresponding amino acid sequences in the human enzyme, with an overall identity of 73% (see legend to Fig. 2) ; the remaining peptide from the bovine enzyme, which showed only 18% identity to any peptide in the human sequence, may have been derived from a nonconserved region or from an impurity in the enzyme preparation. The amino acid sequence of the human enzyme showed similarity only to very short stretches of sequences in the SwissProt data base (release 32, Dec. 1995).
The molecular size of the mature protein (720 aa or 80 kDa, not including carbohydrate residues) as well as its amino terminal sequence indicate that the two activity bands seen on SDS/PAGE of the bovine enzyme were the monomeric and dimeric forms of a-N-acetylglucosaminidase. The dimer, which we had used for amino acid sequence analysis, apparently does not readily dissociate even under denaturing conditions. Others have also shown enzyme of -80 kDa as well as larger forms likely to be dimers and tetramers (12, 23, 24) .
Chromosomal Locus and Architecture of the NAGLU Gene.
Most of the cDNA sequence had been found in the 5'-flanking region of EDH17B, the gene encoding 17-,3-hydroxysteroid dehydrogenase, GenBank accession no. M84472 (25) . Because the locus ofEDH17B is chromosome 17q21 (26) , this is also the locus of NAGLU. A longer sequence flanking EDH17B, encompassing the entire NAGLU gene (GenBank accession no. U34879), became available during preparation of this manuscript.
The architecture of the NAGLU gene is shown in Fig. 3 . The placement of introns was determined by comparison with the cDNA except in the case of intron 1, which was identified by RT-PCR of the corresponding section of fibroblast RNA. The NAGLU gene, interrupted by five introns, is 8.2 kb long from translation start to polyadenylylation site. The first exon is indicated provisionally as containing an additional 0.3 kb of untranslated sequence, based on primer extension studies that showed an apparent transcription start site 332 and 321 nucleotides upstream of the initiating methionine (H.G.Z. and E.F.N., unpublished results). But because that region contains neither TATA box nor SP1 sites and is not particularly G+C-rich, the untranslated region may extend even further upstream.
Mutations in Patients with Sanfilippo B Syndrome. Several mutations were identified by preliminary screening of the NAGLU gene by PCR-SSCP (18) followed by sequence analysis of the amplified segments that had altered mobility. Cell line IT 154 proved homozygous for a 10-nt deletion starting with nucleotide 503 (Fig. 4A) ; the deletion results in a frameshift and predicts termination 14 codons later. Cell line GM 00156 proved homozygous for a C->T transition at nucleotide 1876, resulting in a termination codon at position 626 instead of the normal arginine (Fig. 4B) . Cell line GM 02552 proved to be compound heterozygous for a C->T transition at nucleotide 889, resulting in a stop in lieu of arginine at codon 297 (Fig. 4C) 
